Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18108-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CXCL17 antibody
- Antibody type
- Polyclonal
- Description
- CXCL17 antibody (Cat. #18108-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme.
A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma.
Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Wang R, Li Q, Chu X, Li N, Liang H, He F
Metabolic brain disease 2023 Oct;38(7):2289-2300
Metabolic brain disease 2023 Oct;38(7):2289-2300
A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma.
Jiang Z, Luo Y, Zhang L, Li H, Pan C, Yang H, Cheng T, Chen J
Cancers 2022 Jul 30;14(15)
Cancers 2022 Jul 30;14(15)
Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
Zhang X, Peng L, Luo Y, Zhang S, Pu Y, Chen Y, Guo W, Yao J, Shao M, Fan W, Cui Q, Xi Y, Sun Y, Niu X, Zhao X, Chen L, Wang Y, Liu Y, Yang X, Wang C, Zhong C, Tan W, Wang J, Wu C, Lin D
Nature communications 2021 Sep 6;12(1):5291
Nature communications 2021 Sep 6;12(1):5291
CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S, Makino K, Jinnin M, Sawamura S, Kawano Y, Ide M, Kajihara I, Makino T, Fukushima S, Ihn H
Journal of dermatological science 2020 Dec;100(3):183-191
Journal of dermatological science 2020 Dec;100(3):183-191
No comments: Submit comment
No validations: Submit validation data